Gene · 4739
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Genes Related to Invadopodia Formation and CTTN in Oral Squamous Cell Carcinoma-A Systematic Gene Expression Analysis. | Curr Issues Mol Biol | 2023 | 37623256 | PubTator, text mining | PubMed |
| Isorhapontigenin (ISO) inhibits malignant cell transformation, migration, and invasion through MEG3/NEDD9 signaling in Cr(VI)-transformed cells. | Toxicol Appl Pharmacol | 2023 | 37619952 | PubTator, text mining | PubMed |
| Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. | Front Oncol | 2023 | 37614497 | PubTator, text mining | PubMed |
| Cas4/1 dual nuclease activities enable prespacer maturation and directional integration in a type I-G CRISPR-Cas system. | J Biol Chem | 2023 | 37607619 | PubTator, text mining | PubMed |
| Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. | Mol Cancer | 2023 | 37598158 | PubTator, text mining | PubMed |
| Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model. | Int J Mol Sci | 2023 | 37511298 | PubTator, text mining | PubMed |
| Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies. | Genes (Basel) | 2023 | 37510333 | PubTator, text mining | PubMed |
| SYNPO2 upregulation is an unfavorable prognostic factor for nasopharyngeal carcinoma patients. | Medicine (Baltimore) | 2023 | 37505159 | PubTator, text mining | PubMed |
| Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management. | Eur Radiol | 2023 | 37500964 | PubTator, text mining | PubMed |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | 37493631 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| Phages are unrecognized players in the ecology of the oral pathogen Porphyromonas gingivalis. | Microbiome | 2023 | 37491415 | PubTator, text mining | PubMed |
| Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways. | Heliyon | 2023 | 37484409 | PubTator, text mining | PubMed |
| Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. | Int J Mol Sci | 2023 | 37445737 | PubTator, text mining | PubMed |
| Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology. | Cancers (Basel) | 2023 | 37444576 | PubTator, text mining | PubMed |
| WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. | Cancers (Basel) | 2023 | 37444539 | PubTator, text mining | PubMed |
| A TGF-β-responsive enhancer regulates SRC expression and epithelial-mesenchymal transition-associated cell migration. | J Cell Sci | 2023 | 37439249 | PubTator, text mining | PubMed |
| IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation. | Nat Commun | 2023 | 37429848 | PubTator, text mining | PubMed |
| Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape. | Oncol Res | 2023 | 37415743 | PubTator, text mining | PubMed |
| NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications. | Int J Mol Sci | 2023 | 37373427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4739/papers?page=8